Pain Management

Migraines

More in Migraines

Oral Agent Shows Promise in Treatment-Resistant Migraine

Gepant reduced number of monthly migraine days

Apr 20, 2023
 A photo of a bottle of 60 mg Qulipta tablets over a photo of a woman wincing with her fingers pressing her temples.
Cluster Headache, Migraine Linked to Circadian System

Findings may influence treatment approaches for some patients

Mar 29, 2023
A medical illustration of the concept of circadian rhythm with a cut away human looking at the sun
Evidence COVID Began in Raccoon Dog; Migraine Drug Recall; FDA Mum on Spring Booster

Health news and commentary from around the Web gathered by MedPage Today staff

Mar 17, 2023
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.
Fast-Acting Nasal Spray for Migraine Snags FDA Approval

In pivotal trial, zavegepant demonstrated pain relief as early as 15 minutes

Mar 10, 2023
FDA APPROVED zavegepant (Zavzpret) over a computer rendering of a migraine aura over a photo of a field.
Cluster Headache Hits Women Harder, but Is Often Misdiagnosed

Awareness of sex differences in symptoms, triggers may increase diagnosis and treatment in women

Dec 21, 2022
A photo of a grimacing woman sitting up in bed, her left hand touching her left temple
Ultra-High-Res MRI Highlights Migraine Brain Changes

Patients had significant changes in perivascular spaces

Dec 01, 2022
RSNA over a photo of McCormick Place Convention center in Chicago, Illinois.
Migraines Predict Poor Sleep in Premenopausal Women, Study Finds

Clinicians should ask female migraineurs about sleep, irrespective of menopause status

Oct 18, 2022
NAMS over a photo of the Hyatt Regency in Atlanta, Georgia
Drug Eases Migraine Days for Patients Who Failed Prior Treatments

Anti-CGRP reduced migraine frequency after first day of treatment

Jul 03, 2022
A computer rendering of a monoclonal antibody.
Migraine Disability Rising in the U.S.

Proportion of people with moderate or severe migraine disability nearly doubled

Jun 16, 2022
AHS over a photo of the Gaylord Rockies Resort & Convention Center in Aurora, Colorado
Rimegepant Safe, Well-Tolerated for Migraine When Used Every Other Day

Trial evaluates a single drug to both treat and prevent migraine

Jun 15, 2022
AHS over a photo of the Gaylord Rockies Resort & Convention Center in Aurora, Colorado
How Safe Are Migraine Drugs for People With Cardiovascular Conditions?

Analysis is a first step to question how safe known treatments are, researcher says

Jun 13, 2022
AHS over a photo of the Gaylord Rockies Resort & Convention Center in Aurora, Colorado
Less Headache Disability in Kids During COVID Pandemic

Findings persisted even after adjusting for headache frequency

Jun 13, 2022
AHS over a photo of the Gaylord Rockies Resort & Convention Center in Aurora, Colorado
Intranasal Zavegepant Shows Promise in Acute Migraine

Pain relief as early as 15 minutes post-dose

Jun 12, 2022
AHS over a photo of the Gaylord Rockies Resort & Convention Center in Aurora, Colorado
Placebo Responses in Migraine Prevention Trials Tick Upward Over Time

How this may affect future research is unclear

Jun 12, 2022
AHS over a photo of the Gaylord Rockies Resort & Convention Center in Aurora, Colorado
More in Migraines

Continuing Medical Education